awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38851093-2CFAC0DC-8B6D-44A9-B725-2BF261B352FB
Q38851093-2CFAC0DC-8B6D-44A9-B725-2BF261B352FB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38851093-2CFAC0DC-8B6D-44A9-B725-2BF261B352FB
Advances in the treatment of cutaneous lupus erythematosus.
P2860
Q38851093-2CFAC0DC-8B6D-44A9-B725-2BF261B352FB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38851093-2CFAC0DC-8B6D-44A9-B725-2BF261B352FB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b4ff7734b2270661b7098f7cbecf0ae9b7cbbdbf
P2860
A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-α) in patients with systemic lupus erythematosus (ROSE).